Zhang et al. further showed that melittin can stimulate Schwann cell proliferation under hyperglycemic conditions via the Crabp2/Wnt/β-catenin pathway, highlighting the context-dependent selectivity of melittin’s action, which may have implications for both targeted cancer and regenerative therapies [57]. This evidence concerns the gene CRABP2 and cancer.